Previously, Wang et al. investigated the role of sodium-dependent glucose transporter 1 (SGLT1) in HER2+ breast cancer, focusing on its stabilisation by HER2 and its involvement in oncogenic signalling [100]. This evidence concerns the gene ERBB2 and breast cancer.